Skip to main content
BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.692
-0.498 (-41.82%)
At close: Dec 20, 2024, 4:00 PM
0.730
+0.038 (5.45%)
After-hours: Dec 20, 2024, 7:45 PM EST

BioAtla Revenue

BioAtla had revenue of $11.00M in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $11.00M.

Revenue (ttm)
$11.00M
Revenue Growth
n/a
P/S Ratio
3.03
Revenue / Employee
$169,231
Employees
65
Market Cap
33.47M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021250.00K-179.00K-41.72%
Dec 31, 2020429.00K-4.77M-91.75%
Dec 31, 20195.20M-5.43M-51.07%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Outset Medical 114.73M
CareCloud 111.01M
Atara Biotherapeutics 100.44M
Scilex Holding Company 50.83M
Aadi Bioscience 25.07M
DBV Technologies 12.52M
WORK Medical Technology Group LTD 9.86M
Pheton Holdings 572.29K
Revenue Rankings

BCAB News

More News